News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,411 Results
Type
Article (639)
Press Release (6772)
Section
Business (1266)
Career Advice (24)
Deals (241)
Drug Delivery (1)
Drug Development (1062)
Employer Resources (1)
FDA (345)
Job Trends (173)
News (3160)
Policy (452)
Tag
Academia (37)
Allergies (2)
Alliances (388)
Alzheimer's disease (82)
Approvals (361)
Bankruptcy (4)
Best Places to Work (168)
Biosimilars (1)
Breast cancer (1)
Cancer (18)
Cardiovascular disease (4)
Career advice (20)
CAR-T (1)
Cell therapy (3)
Clinical research (961)
Collaboration (12)
Complete response letters (1)
COVID-19 (17)
C-suite (3)
Cystic fibrosis (2)
Data (101)
Denatured (1)
Depression (9)
Diabetes (3)
Diagnostics (22)
Digital health (1)
Drug pricing (3)
Drug shortages (1)
Earnings (453)
Employer resources (1)
Events (638)
Executive appointments (9)
FDA (400)
Fibrodysplasia Ossificans Progressiva (1)
Funding (15)
Gene therapy (2)
GLP-1 (5)
Government (62)
Grass and pollen (1)
Guidances (4)
Healthcare (231)
Huntington's disease (3)
Immunology and inflammation (2)
Indications (2)
Infectious disease (17)
Inflammatory bowel disease (6)
Intellectual property (1)
Interviews (6)
IPO (76)
Job creations (12)
Job search strategy (15)
Layoffs (7)
Leadership (1)
Legal (75)
Lung cancer (3)
Management (1)
Manufacturing (3)
Medical device (268)
Medtech (270)
Mergers & acquisitions (165)
Metabolic disorders (5)
Multiple sclerosis (1)
Neurodegenerative disease (8)
Neuroscience (108)
NextGen: Class of 2026 (105)
Non-profit (49)
Obesity (1)
Opinion (4)
Ovarian cancer (1)
Pain (21)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (4)
Patient recruitment (3)
People (298)
Phase 1 (198)
Phase 2 (355)
Phase 3 (360)
Pipeline (55)
Policy (2)
Postmarket research (98)
Preclinical (70)
Press Release (1)
Psychedelics (1)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (29)
Regulatory (394)
Research institute (19)
Resumes & cover letters (2)
Schizophrenia (4)
Series A (2)
Series B (5)
Special edition (1)
Sponsored (1)
Startups (43)
Tariffs (1)
Venture capital (1)
Weight loss (1)
Women's health (2)
Worklife (2)
Date
Last 7 days (3)
Last 30 days (19)
Last 365 days (286)
2026 (29)
2025 (296)
2024 (370)
2023 (425)
2022 (577)
2021 (535)
2020 (612)
2019 (576)
2018 (426)
2017 (357)
2016 (336)
2015 (336)
2014 (246)
2013 (226)
2012 (220)
2011 (289)
2010 (245)
Location
Africa (11)
Alaska (1)
Arizona (1)
Asia (523)
Australia (96)
California (161)
Canada (21)
China (15)
Colorado (5)
Connecticut (1)
Delaware (7)
Europe (908)
Florida (26)
Georgia (2)
Idaho (3)
Illinois (8)
Indiana (6)
Japan (31)
Maryland (8)
Massachusetts (80)
Michigan (2)
Minnesota (12)
Mississippi (1)
New Hampshire (14)
New Jersey (43)
New York (26)
North Carolina (5)
Northern California (59)
Ohio (3)
Pennsylvania (6)
South America (11)
Southern California (92)
Texas (4)
United States (427)
Utah (1)
Virginia (1)
Washington D.C. (2)
Washington State (2)
Wisconsin (1)
7,411 Results for "relievant medsystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc.
November 17, 2023
·
5 min read
Press Releases
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer
November 21, 2025
·
2 min read
Deals
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company.
September 19, 2023
·
6 min read
Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain
Relievant Medsystems today announced the release of next-generation Intracept ® Access Instruments.
July 14, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.
October 3, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Relievant Medsystems announced the presentation of four-year pooled results from two prospective clinical trials that further demonstrate the safety, effectiveness and long-term durability of the Intracept® Procedure for patients with vertebrogenic pain.
July 20, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization
Relievant Medsystems announced the publication of a pooled analysis from three prospective clinical trials that demonstrates the impact of the company’s Intracept® Procedure on significantly reducing the long-term utilization of additional treatments for low back pain.
September 12, 2023
·
4 min read
Press Releases
Minimally Invasive Procedure Relieves Painful Symptoms of Knee Osteoarthritis
August 14, 2025
·
6 min read
BioMidwest
Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
Relievant Medsystems announced the publication of three-year pooled results from two prospective clinical trials that further validate the safety, effectiveness and long-term durability of the Intracept® Procedure for patients with vertebrogenic pain.
June 15, 2023
·
3 min read
Press Releases
FemDx Medsystems Announces Successful First-in-Human Study
April 29, 2025
·
2 min read
1 of 742
Next
